Cts CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
CTS Corporation announced its second quarter 2026 financial results, showcasing a 7.0% increase in net sales and a significant improvement in gross margin percentage.
NYSE
CTS Corporation announced a significant increase in net sales and earnings for the first quarter of 2026, driven by strong performance in diversified end markets and operational efficiencies.
NYSE
CTS Corporation reported an 8% increase in Q3 net sales to $143 million, driven by diversified markets, but net earnings fell 24.3% to $13.7 million due to higher tax expense and environmental costs.
NYSE
CTS Corporation announced significant increases in net earnings and gross margin for the second quarter and first half of 2025, fueled by robust growth in medical, industrial, and aerospace & defense sectors, despite a decline in transportation sales.
NYSE
CTS Corporation's Q1 2025 results show flat net sales year-over-year but an increase in gross margin driven by improved sales mix and foreign exchange benefits.
NYSE
CTS Corporation's Q3 2024 results show a slight decrease in net sales but an increase in gross margin, influenced by a recent acquisition and market dynamics.
NYSE
CTS Corporation's second-quarter 2024 results show a decrease in net sales, primarily driven by lower transportation market volumes, while the company continues restructuring efforts to align costs with demand.
NYSE
CTS Corporation's first quarter results show a decrease in net sales and earnings compared to the same period last year, primarily due to lower volumes in the industrial and transportation markets.